Methyl 2-amino-3,6-dichlorobenzoate

Catalog No.: 
ACFTNS402
CAS No.: 
40188-85-0
Molecular Formula: 
C8H7Cl2NO2
Molecular Weight: 
220.05
Methyl 2-amino-3,6-dichlorobenzoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg97%$123.00In stockInquiry
100mg97%$199.00In stockInquiry
250mg97%$302.00In stockInquiry
1g97%$658.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 2-amino-3,6-dichlorobenzoate
IUPAC Namemethyl 2-amino-3,6-dichlorobenzoate
Molecular FormulaC8H7Cl2NO2
Molecular Weight220.05
SMILESO=C(OC)C1=C(Cl)C=CC(Cl)=C1N
InChI KeyFAASGTKBZHSTPA-UHFFFAOYSA-N
SynonymBenzoic acid, 2-amino-3,6-dichloro-, methyl ester;2-Amino-3,6-dichloro-benzoic acid methyl ester;Methyl 2-amino-3,6-dichlorobenzoate
CAS No.40188-85-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACFTNS402 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  2. Plus
  3. ACLYSA371 route compound structure diagram
    ACLYSA3713032-32-4In Stock
  4. Then
  5. ACFTNS402 route product structure diagram
    ACFTNS40240188-85-0In Stock
Inquiry

2. ACFTNS402 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFTNS402 route product structure diagram
    ACFTNS40240188-85-0In Stock
Inquiry

3. ACFTNS402 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFTNS402 route product structure diagram
    ACFTNS40240188-85-0In Stock
Inquiry

Comments (0)